| 1,3-dinitrobenzene | increases expression | EXP | | 6480464 | 3-dinitrobenzene results in increased expression of GSN mRNA | CTD | PMID:21983209 |
| 17beta-estradiol | affects expression | ISO | RGD:1346375 | 6480464 | Estradiol affects the expression of GSN mRNA | CTD | PMID:22574217 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1346375 | 6480464 | [Estradiol results in increased activity of ESR1 protein] which results in decreased expression of GSN mRNA | CTD | PMID:22403704 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1346375 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSN mRNA | CTD | PMID:20106945 PMID:20044593 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1346375 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSN mRNA | CTD | PMID:20044593 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of GSN mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GSN mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1346375 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSN mRNA | CTD | PMID:20044593 PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1550660 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSN mRNA | CTD | PMID:17035482 PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1550660 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSN mRNA | CTD | PMID:19770486 PMID:17035482 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1550660 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSN mRNA | CTD | PMID:17035482 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1550660 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GSN mRNA | CTD | PMID:20044593 |
| 2,3-dimethoxynaphthalene-1,4-dione | decreases expression | ISO | RGD:1346375 | 6480464 | 2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of GSN mRNA | CTD | PMID:17547211 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | RGD:1550660 | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of GSN mRNA] | CTD | PMID:18200517 |
| 2,4,6-trinitrobenzenesulfonic acid | decreases expression | ISO | RGD:1550660 | 6480464 | Trinitrobenzenesulfonic Acid results in decreased expression of GSN mRNA | CTD | PMID:17982090 PMID:18200517 |
| 2,4,6-trinitrobenzenesulfonic acid | decreases expression | ISO | RGD:1550660 | 6480464 | Trinitrobenzenesulfonic Acid results in decreased expression of GSN mRNA | CTD | PMID:18200517 PMID:17982090 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:1550660 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of GSN mRNA | CTD | PMID:18648102 |
| 4-hydroxynon-2-enal | increases expression | ISO | RGD:1550660 | 6480464 | 4-hydroxy-2-nonenal results in increased expression of GSN mRNA | CTD | PMID:19191707 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1346375 | 6480464 | decitabine inhibits the reaction [Smoke results in decreased expression of GSN mRNA] | CTD | PMID:21095227 |
| aflatoxin B1 | affects expression | ISO | RGD:1346375 | 6480464 | Aflatoxin B1 affects the expression of GSN protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | ISO | RGD:1346375 | 6480464 | Aflatoxin B1 results in increased expression of GSN mRNA | CTD | PMID:21632981 PMID:22100608 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1550660 | 6480464 | Tretinoin results in increased expression of GSN mRNA | CTD | PMID:16604517 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1346375 | 6480464 | Tretinoin results in increased expression of GSN mRNA | CTD | PMID:15498508 PMID:16054129 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1346375 | 6480464 | Tretinoin results in increased expression of GSN mRNA | CTD | PMID:16054129 PMID:15498508 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1346375 | 6480464 | Tretinoin results in increased expression of GSN mRNA | CTD | PMID:16054129 |
| amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of GSN mRNA | CTD | PMID:17991464 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1550660 | 6480464 | Benzo(a)pyrene results in decreased expression of GSN mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1550660 | 6480464 | Benzo(a)pyrene results in decreased expression of GSN mRNA | CTD | PMID:19770486 PMID:22228805 |
| benzo[a]pyrene | increases expression | ISO | RGD:1346375 | 6480464 | Benzo(a)pyrene results in increased expression of GSN mRNA | CTD | PMID:22316170 |
| bilirubin | decreases expression | ISO | RGD:1346375 | 6480464 | Bilirubin results in decreased expression of GSN mRNA | CTD | PMID:20196124 |
| bisphenol A | multiple interactions | ISO | RGD:1346375 | 6480464 | [bisphenol A results in increased activity of ESR1 protein] which results in decreased expression of GSN mRNA | CTD | PMID:22403704 |
| cadmium atom | decreases expression | ISO | RGD:1346375 | 6480464 | Cadmium results in decreased expression of GSN mRNA | CTD | PMID:17547211 |
| cadmium dichloride | decreases expression | ISO | RGD:1346375 | 6480464 | Cadmium Chloride results in decreased expression of GSN mRNA | CTD | PMID:17547211 |
| cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of GSN promoter | CTD | PMID:22457795 |
| calcitriol | increases expression | ISO | RGD:1346375 | 6480464 | Calcitriol results in increased expression of GSN mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:1346375 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of GSN mRNA | CTD | PMID:21592394 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:1550660 | 6480464 | Ciguatoxins affects the expression of GSN mRNA | CTD | PMID:18353800 |
| cisplatin | increases expression | ISO | RGD:1550660 | 6480464 | Cisplatin results in increased expression of GSN mRNA | CTD | PMID:21151649 |
| cobalt dichloride | decreases expression | ISO | RGD:1346375 | 6480464 | cobaltous chloride results in decreased expression of GSN mRNA | CTD | PMID:19320972 |
| cocaine | decreases expression | ISO | RGD:1346375 | 6480464 | Cocaine results in decreased expression of GSN mRNA | CTD | PMID:12629581 |
| cumene | decreases expression | ISO | RGD:1550660 | 6480464 | cumene results in decreased expression of GSN mRNA | CTD | PMID:18648096 |
| curcumin | multiple interactions | ISO | RGD:1550660 | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of GSN mRNA] | CTD | PMID:18200517 |
| cyclosporin A | decreases expression | ISO | RGD:1346375 | 6480464 | Cyclosporine results in decreased expression of GSN mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:1346375 | 6480464 | Cyclosporine results in decreased expression of GSN mRNA | CTD | PMID:20106945 PMID:21632981 |
| DDT | multiple interactions | ISO | RGD:1346375 | 6480464 | [DDT results in increased activity of ESR1 protein] which results in decreased expression of GSN mRNA | CTD | PMID:22403704 |
| dibutyl phthalate | increases expression | ISO | RGD:1550660 | 6480464 | Dibutyl Phthalate results in increased expression of GSN mRNA | CTD | PMID:21266533 |
| diethyl maleate | decreases reduction | ISO | RGD:1550660 | 6480464 | diethyl maleate results in decreased reduction of GSN protein | CTD | PMID:19843705 |
| doxorubicin | increases expression | ISO | RGD:1550660 | 6480464 | Doxorubicin results in increased expression of GSN mRNA | CTD | PMID:15033991 |
| elemental selenium | increases expression | ISO | RGD:1346375 | 6480464 | Selenium results in increased expression of GSN mRNA | CTD | PMID:19244175 |
| hyaluronic acid | multiple interactions | EXP | | 6480464 | [Hyaluronic Acid analog co-treated with Hydrogen Peroxide] results in decreased expression of GSN protein | CTD | PMID:23178681 |
| hyaluronic acid | decreases expression | EXP | | 6480464 | Hyaluronic Acid analog results in decreased expression of GSN protein | CTD | PMID:23178681 |
| hydralazine | multiple interactions | ISO | RGD:1346375 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of GSN mRNA | CTD | PMID:17183730 |
| hydrogen peroxide | affects expression | ISO | RGD:1346375 | 6480464 | Hydrogen Peroxide affects the expression of GSN mRNA | CTD | PMID:20044591 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | [Hyaluronic Acid analog co-treated with Hydrogen Peroxide] results in decreased expression of GSN protein | CTD | PMID:23178681 |
| hydrogen peroxide | decreases secretion | ISO | RGD:1550660 | 6480464 | Hydrogen Peroxide results in decreased secretion of GSN mRNA | CTD | PMID:21179422 |
| indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of GSN mRNA | CTD | PMID:21396975 |
| menadione | affects response to substance | ISO | RGD:1346375 | 6480464 | GSN mRNA affects the susceptibility to Vitamin K 3 | CTD | PMID:15033777 PMID:14652020 |
| menadione | affects response to substance | ISO | RGD:1346375 | 6480464 | GSN mRNA affects the susceptibility to Vitamin K 3 | CTD | PMID:14652020 PMID:15033777 |
| mercury atom | decreases expression | ISO | RGD:1346375 | 6480464 | Mercury results in decreased expression of GSN mRNA | CTD | PMID:17547211 |
| mercury atom | affects expression | ISO | RGD:1346375 | 6480464 | Mercury affects the expression of GSN protein | CTD | PMID:22030286 |
| mercury(0) | decreases expression | ISO | RGD:1346375 | 6480464 | Mercury results in decreased expression of GSN mRNA | CTD | PMID:17547211 |
| mercury(0) | affects expression | ISO | RGD:1346375 | 6480464 | Mercury affects the expression of GSN protein | CTD | PMID:22030286 |
| metformin | increases expression | ISO | RGD:1346375 | 6480464 | Metformin results in increased expression of GSN mRNA | CTD | PMID:19022234 |
| microcystin-LR | increases expression | ISO | RGD:1550660 | 6480464 | cyanoginosin LR results in increased expression of GSN mRNA | CTD | PMID:17654400 |
| N-nitrosodimethylamine | decreases expression | ISO | RGD:1346375 | 6480464 | Dimethylnitrosamine results in decreased expression of GSN mRNA | CTD | PMID:17547211 |
| nickel sulfate | increases expression | ISO | RGD:1346375 | 6480464 | nickel sulfate results in increased expression of GSN mRNA | CTD | PMID:18651567 |
| nitric oxide | increases expression | ISO | RGD:1550660 | 6480464 | Nitric Oxide deficiency results in increased expression of GSN mRNA | CTD | PMID:15878706 |
| nitroglycerin | increases expression | EXP | | 6480464 | Nitroglycerin results in increased expression of GSN mRNA | CTD | PMID:12187120 |
| paclitaxel | decreases expression | ISO | RGD:1346375 | 6480464 | Paclitaxel results in decreased expression of GSN mRNA | CTD | PMID:15000894 |
| paracetamol | affects expression | ISO | RGD:1550660 | 6480464 | Acetaminophen affects the expression of GSN mRNA | CTD | PMID:17562736 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of GSN protein | CTD | PMID:16099942 |
| phenobarbital | multiple interactions | ISO | RGD:1550660 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of GSN mRNA] | CTD | PMID:19482888 |
| phenobarbital | decreases expression | ISO | RGD:1550660 | 6480464 | Phenobarbital results in decreased expression of GSN mRNA | CTD | PMID:19482888 |
| pirinixic acid | multiple interactions | ISO | RGD:1550660 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GSN mRNA | CTD | PMID:19710929 |
| pirinixic acid | decreases expression | ISO | RGD:1550660 | 6480464 | pirinixic acid results in decreased expression of GSN mRNA | CTD | PMID:17426115 |
| quercetin | increases expression | ISO | RGD:1346375 | 6480464 | Quercetin results in increased expression of GSN mRNA | CTD | PMID:21632981 |
| resveratrol | multiple interactions | ISO | RGD:1346375 | 6480464 | [resveratrol results in increased activity of CASP3 protein] which results in increased cleavage of GSN protein | CTD | PMID:19423619 |
| rosiglitazone | affects expression | ISO | RGD:1346375 | 6480464 | rosiglitazone affects the expression of GSN protein | CTD | PMID:19556978 |
| rosiglitazone | increases expression | ISO | RGD:1346375 | 6480464 | rosiglitazone results in increased expression of GSN protein | CTD | PMID:17535976 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of GSN mRNA | CTD | PMID:21515302 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | ISO | RGD:1550660 | 6480464 | Buthionine Sulfoximine results in increased expression of GSN mRNA | CTD | PMID:15878706 |
| selenium atom | increases expression | ISO | RGD:1346375 | 6480464 | Selenium results in increased expression of GSN mRNA | CTD | PMID:19244175 |
| tamibarotene | increases expression | ISO | RGD:1346375 | 6480464 | Am 80 results in increased expression of GSN mRNA; more ... | CTD | PMID:15498508 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1550660 | 6480464 | tert-Butylhydroperoxide results in increased expression of GSN mRNA | CTD | PMID:15003993 |
| testosterone | multiple interactions | ISO | RGD:1346375 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of GSN mRNA | CTD | PMID:21592394 |
| testosterone | increases expression | ISO | RGD:1550660 | 6480464 | Testosterone results in increased expression of GSN mRNA | CTD | PMID:20403060 |
| testosterone | increases expression | ISO | RGD:1346375 | 6480464 | Testosterone results in increased expression of GSN mRNA | CTD | PMID:21592394 |
| trans-resveratrol | multiple interactions | ISO | RGD:1346375 | 6480464 | [resveratrol results in increased activity of CASP3 protein] which results in increased cleavage of GSN protein | CTD | PMID:19423619 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of GSN mRNA | CTD | PMID:19022234 |
| troglitazone | decreases expression | ISO | RGD:1346375 | 6480464 | troglitazone results in decreased expression of GSN mRNA | CTD | PMID:19022234 |
| urethane | decreases expression | ISO | RGD:1550660 | 6480464 | Urethane results in decreased expression of GSN mRNA | CTD | PMID:16289808 |
| valproic acid | multiple interactions | ISO | RGD:1346375 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of GSN mRNA | CTD | PMID:17183730 |
| valproic acid | increases expression | ISO | RGD:1550660 | 6480464 | Valproic Acid results in increased expression of GSN mRNA | CTD | PMID:20546886 |
| valproic acid | increases expression | ISO | RGD:1346375 | 6480464 | Valproic Acid results in increased expression of GSN mRNA | CTD | PMID:19101580 |